Zhou E

ORCID: 0000-0003-3652-1193 · 3 papers in corpus
review 2026
Cancer medicine ·doi:10.1002/cam4.72292

Gynaecological malignancies account for over 1.4 million new diagnoses, with outcomes constrained by late-stage presentation and chemoresistance. Dysregulated redox homeostasis is a hallmark of tumourigenesis. Tumour cells maintain elevated…

review 2024
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1181183

Traditional Chinese medicine (TCM) is the practical experience and summary of the Chinese nation for thousands of years. It shows great potential in treating various chronic diseases, complex diseases and major infectious diseases, and has …

lab-animal 2019
OncoTargets and therapy ·doi:10.2147/ott.s193787

BACKGROUND AND OBJECTIVE: Mst1-Hippo pathway and mitochondrial fragmentation participate in the progression of several types of cancers. However, their roles in breast cancer requires investigation. The aim of our study is to determine whet…